Looking at tissue samples to guide colon cancer treatment
Part of Cancer, Digestive system clinical trials.
This study collects tissue, blood, and imaging samples from people having surgery for colon cancer or related liver tumors, to learn more about the disease and potentially improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old
- You are scheduled for surgery for colon cancer or a pre-cancerous colon tumor
- The surgery can be open, laparoscopic, or robotic
- You have had a CT scan within the past two months before surgery
- You cannot have cancer that has spread outside the liver (except if it is only in the liver)
- You cannot have had other cancers (except non-melanoma skin cancer) within the last 5 years
- You cannot have a known inherited colon cancer syndrome or microsatellite instability (MSI-high)
- You cannot have significant liver disease or bleeding disorders
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at tissue from colorectal cancer surgery to understand how cancer cells use energy, which may help find better treatments. It is open to adults having surgery for colorectal cancer or liver metastases from colorectal cancer.
This study collects clinical and lab information from people who have surgery for colon cancer (or certain precancer growths) and related spread to organs. It may help researchers better understand colon cancer and improve future care, but it is not a new medication trial.
This study compares different blood tests to find the best way to detect tiny bits of cancer DNA after surgery for stage III colorectal cancer. It aims to help doctors decide if additional chemotherapy is needed to prevent the cancer from coming back.
This study looks at colorectal cancer patients who are planning curative surgery and collects related outcomes and lab “biomarker” information to better understand the disease. Your participation may help researchers connect test results to treatment results over time.
This study looks for early signs that treatment is not working in people with stage IV colon or rectal cancer that has spread only to the liver. It may help doctors adjust care sooner by using regular blood, stool, and tissue samples around liver procedures.
This trial studies a blood test (called ctDNA) in people with colon cancer that has spread to the liver and is being removed with curative surgery. The goal is to see how the blood test can help with planning and improving treatment after surgery.
Hear when a new Colon Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.